Illumina to sell cancer-test maker Grail after latest antitrust ruling

<p>Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive. Read Full Story</p>
<p>The post <a href="https://forextv.com/market-news/illumina-to-sell-cancer-test-maker-grail-after-latest-antitrust-ruling/">Illumina to sell cancer-test maker Grail after latest antitrust ruling</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>